Adjuvant Chemoradiotherapy for Pancreatic Adenocarcinoma
Surgical Oncology Clinics of North America · 2026
DOI: 10.1016/j.soc.2025.04.006 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Surgical Oncology Clinics of North America, 2026. Verfasst von Sylvia S W Ng und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Odette Cancer Center, Sunnybrook Health Sciences Center, University of Toronto, Toronto, Canada. Hauptthemen laut MEDLINE: Carcinoma, Pancreatic Ductal, Pancreatic Neoplasms, Dose Fractionation, Radiation, Antineoplastic Combined Chemotherapy Protocols. Die Arbeit nennt 36 Literaturangaben.
Abstract (Originalsprache)
While the clinical benefits of adjuvant chemotherapy are well documented in resected pancreatic ductal adenocarcinoma regardless of surgical margin status, the role of adding chemoradiation to adjuvant chemotherapy is an ongoing debate due to the paucity of clinical studies that concurrently incorporated contemporary chemotherapy regimens such as mFOLFIRINOX or gemcitabine/capecitabine with modern day radiation dose fractionation and techniques. Adjuvant chemoradiation should be tailored to individual patients and supported by multidisciplinary discussion. In R1 patients with good performance status following completion of adjuvant mFOLFIRINOX or gemcitabine/capecitabine, adjuvant chemoradiation may be considered with the intent to decrease the risk of local recurrence.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiation Oncology, Odette Cancer Center, Sunnybrook Health Sciences Center, University of Toronto, Toronto, Canada.
- Department of Medical Oncology, Odette Cancer Center, Sunnybrook Health Sciences Center, University of Toronto, Toronto, Canada.
- Department of Surgery, Odette Cancer Center, Sunnybrook Health Sciences Center, University of Toronto, Toronto, Canada. Electronic address: natalie.coburn@sunnybrook.ca.
Zitieren
APA
Ng, S. S. W., Perera, S., & Coburn, N. G. (2026). Adjuvant Chemoradiotherapy for Pancreatic Adenocarcinoma. Surgical Oncology Clinics of North America. https://doi.org/10.1016/j.soc.2025.04.006
Vancouver
Ng SSW, Perera S, Coburn NG. Adjuvant Chemoradiotherapy for Pancreatic Adenocarcinoma. Surgical Oncology Clinics of North America. 2026. doi:10.1016/j.soc.2025.04.006
BibTeX
@article{Ng2026,
author = {Ng, Sylvia S W and Perera, Sheron and Coburn, Natalie G},
title = {Adjuvant Chemoradiotherapy for Pancreatic Adenocarcinoma},
journal = {Surgical Oncology Clinics of North America},
year = {2026},
doi = {10.1016/j.soc.2025.04.006}
}
EUVIMED